O’Brien, S., Furman, R. R., Coutre, S. E., Sharman, J. P., Burger, J. A., Blum, K. A., . . . Byrd, J. C. (2013). Ibrutinib as initial therapy for elderly patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: An open-label, multicentre, phase 1b/2 trial.
Stile di citazione ChicagoO’Brien, Susan, et al. Ibrutinib As Initial Therapy for Elderly Patients With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma: An Open-label, Multicentre, Phase 1b/2 Trial. 2013.
Citazione MLAO’Brien, Susan, et al. Ibrutinib As Initial Therapy for Elderly Patients With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma: An Open-label, Multicentre, Phase 1b/2 Trial. 2013.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.